BALCAO · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP
Global Innovative Platforms Inc. GIPL
5 fiscal years on record · USD · FY2025 reported · SEC filings only
$0
$-718,251
Growth
—
Revenue, FY2025 · full 5-year series below
Revenue $
Net income $
FY2025 · Revenue 0.0 · Net income -718251.0
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
—
ROE
Not applicable: equity was negative in this period, so return on equity has no meaning.
Each USD of equity lost 930 cents this year.
The 5-year record
5 fiscal years
Every figure from documents filed with the SEC · USD
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue $B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating income $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| EBITDA $B | · | · | · | · | · |
| Income tax $B | · | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| EPS, diluted $ | −0.02 | −0.01 | −0.46 | −0.08 | −0.12 |
| Dividend / sh $ | · | · | · | · | · |
| Payout % | · | · | · | · | · |
| ROE % | −929.6 | · | · | · | · |
| Shares out B | 0.04 | 0.03 | 0.00 | 0.00 | 0.00 |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 20 reconciliationsAUDITED
Reconciled in 5 of 19 fiscal years. 56 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivitySurgical & Medical Instruments & Apparatus
Listed onOTC market
Incorporated inDelaware
Fiscal year endsSeptember 30
SEC categoryemerging growth company, smaller reporting company
Data on record since2021